Hu et al. [24] found that ATRX mutations activate the BRD-dependent immunosuppressive transcriptome and immune escape mechanisms in IDH1 R132H-mutated astrocytoma cells. This evidence concerns the gene ATRX and astrocytoma (excluding glioblastoma).